BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

364 related articles for article (PubMed ID: 19800579)

  • 21. Salt-inducible kinase 3 is a novel mitotic regulator and a target for enhancing antimitotic therapeutic-mediated cell death.
    Chen H; Huang S; Han X; Zhang J; Shan C; Tsang YH; Ma HT; Poon RY
    Cell Death Dis; 2014 Apr; 5(4):e1177. PubMed ID: 24743732
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Imbalance of the spindle-assembly checkpoint promotes spindle poison-mediated cytotoxicity with distinct kinetics.
    Zeng X; Xu WK; Lok TM; Ma HT; Poon RYC
    Cell Death Dis; 2019 Apr; 10(4):314. PubMed ID: 30952840
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Targeting mitotic exit with hyperthermia or APC/C inhibition to increase paclitaxel efficacy.
    Giovinazzi S; Bellapu D; Morozov VM; Ishov AM
    Cell Cycle; 2013 Aug; 12(16):2598-607. PubMed ID: 23907120
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Overexpression of Cdc20 leads to impairment of the spindle assembly checkpoint and aneuploidization in oral cancer.
    Mondal G; Sengupta S; Panda CK; Gollin SM; Saunders WS; Roychoudhury S
    Carcinogenesis; 2007 Jan; 28(1):81-92. PubMed ID: 16777988
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Delaying mitotic exit downregulates FLIP expression and strongly sensitizes tumor cells to TRAIL.
    Sánchez-Pérez T; Medema RH; López-Rivas A
    Oncogene; 2015 Jan; 34(5):661-9. PubMed ID: 24488010
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cyclin B1 is an efficacy-predicting biomarker for Chk1 inhibitors.
    Xiao Z; Xue J; Gu WZ; Bui M; Li G; Tao ZF; Lin NH; Sowin TJ; Zhang H
    Biomarkers; 2008 Sep; 13(6):579-96. PubMed ID: 18671143
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mitosis and apoptosis: how is the balance set?
    Topham CH; Taylor SS
    Curr Opin Cell Biol; 2013 Dec; 25(6):780-5. PubMed ID: 23890995
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cyclin A and Nek2A: APC/C-Cdc20 substrates invisible to the mitotic spindle checkpoint.
    van Zon W; Wolthuis RM
    Biochem Soc Trans; 2010 Feb; 38(Pt 1):72-7. PubMed ID: 20074038
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mitotic spindle checkpoint inactivation by trichostatin a defines a mechanism for increasing cancer cell killing by microtubule-disrupting agents.
    Dowling M; Voong KR; Kim M; Keutmann MK; Harris E; Kao GD
    Cancer Biol Ther; 2005 Feb; 4(2):197-206. PubMed ID: 15753652
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Sustained spindle-assembly checkpoint response requires de novo transcription and translation of cyclin B1.
    Mena AL; Lam EW; Chatterjee S
    PLoS One; 2010 Sep; 5(9):. PubMed ID: 20927403
    [TBL] [Abstract][Full Text] [Related]  

  • 31. G2 cell cycle arrest, down-regulation of cyclin B, and induction of mitotic catastrophe by the flavoprotein inhibitor diphenyleneiodonium.
    Scaife RM
    Mol Cancer Ther; 2004 Oct; 3(10):1229-37. PubMed ID: 15486190
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A functional genomic screen identifies a role for TAO1 kinase in spindle-checkpoint signalling.
    Draviam VM; Stegmeier F; Nalepa G; Sowa ME; Chen J; Liang A; Hannon GJ; Sorger PK; Harper JW; Elledge SJ
    Nat Cell Biol; 2007 May; 9(5):556-64. PubMed ID: 17417629
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cyclin B1 is rate limiting but not essential for mitotic entry and progression in mammalian somatic cells.
    Soni DV; Sramkoski RM; Lam M; Stefan T; Jacobberger JW
    Cell Cycle; 2008 May; 7(9):1285-300. PubMed ID: 18414058
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Microtubules do not promote mitotic slippage when the spindle assembly checkpoint cannot be satisfied.
    Brito DA; Yang Z; Rieder CL
    J Cell Biol; 2008 Aug; 182(4):623-9. PubMed ID: 18710927
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The Fcp1-Wee1-Cdk1 axis affects spindle assembly checkpoint robustness and sensitivity to antimicrotubule cancer drugs.
    Visconti R; Della Monica R; Palazzo L; D'Alessio F; Raia M; Improta S; Villa MR; Del Vecchio L; Grieco D
    Cell Death Differ; 2015 Sep; 22(9):1551-60. PubMed ID: 25744022
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Length of mitotic arrest induced by microtubule-stabilizing drugs determines cell death after mitotic exit.
    Bekier ME; Fischbach R; Lee J; Taylor WR
    Mol Cancer Ther; 2009 Jun; 8(6):1646-54. PubMed ID: 19509263
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Post-slippage multinucleation renders cytotoxic variation in anti-mitotic drugs that target the microtubules or mitotic spindle.
    Zhu Y; Zhou Y; Shi J
    Cell Cycle; 2014; 13(11):1756-64. PubMed ID: 24694730
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Phosphorylation of Bcl-2 is a marker of M phase events and not a determinant of apoptosis.
    Ling YH; Tornos C; Perez-Soler R
    J Biol Chem; 1998 Jul; 273(30):18984-91. PubMed ID: 9668078
    [TBL] [Abstract][Full Text] [Related]  

  • 39. 6,7-Dimethoxy-3-(3-methoxyphenyl)isoquinolin-1-amine induces mitotic arrest and apoptotic cell death through the activation of spindle assembly checkpoint in human cervical cancer cells.
    Chung KS; Choi HE; Shin JS; Cho YW; Choi JH; Cho WJ; Lee KT
    Carcinogenesis; 2013 Aug; 34(8):1852-60. PubMed ID: 23615402
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The G2-to-M Transition Is Ensured by a Dual Mechanism that Protects Cyclin B from Degradation by Cdc20-Activated APC/C.
    Lara-Gonzalez P; Moyle MW; Budrewicz J; Mendoza-Lopez J; Oegema K; Desai A
    Dev Cell; 2019 Nov; 51(3):313-325.e10. PubMed ID: 31588029
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.